Open PDF Version
SAN DIEGO, Calif. – October 18, 2006 - Pharmatek Laboratories – a premier pharmaceutical
chemistry development organization supporting the pharmaceutical industry – today announced
that its chief executive officer and chief scientific officer Jeffrey A. Bibbs will speak at the
October 18, 2006 BioScience Forum at the Clarion Hotel, Millbrae, California.
Bibbs' presentation, titled "Strategies for Rapid Development of Pharmaceutical Formulations,"
will describe approaches for streamlining formulation development of small molecule drug
candidates. Using case studies, he will present formulation strategies for several therapeutic
areas, including rheumatoid arthritis, obesity, and cancer. Bibbs will discuss formulation support
issues, such as analytical methods and key preformulation studies, and how these aspects
influence formulation development. Considerations for physiochemical characteristics will be
discussed, as well as other important factors, such as mode of administration and manufacturing.
A recognized expert in drug development with more than fifteen years experience, Bibbs has
worked as a pharmaceutical chemist in academia, pharmaceutical companies and contract
research organizations. His background includes preclinical drug development, medicinal
chemistry and physical organic chemistry. Under Bibbs' direction as CSO, Pharmatek has been
involved with over 100 IND applications.
Bibbs worked in medicinal chemistry and drug development for over seven years at Amylin
Pharmaceuticals prior to founding Pharmatek. He is an instructor at University of California, San
Diego Extension, teaching classes in drug development and formulation development. Bibbs is a
co-founder of Diakron Pharmaceuticals, a pharmaceutical company focused on cardiovascular
disease. He earned his Ph.D. from the University of Kansas and was a postdoctoral fellow at
Texas A&M and The Scripps Research Institute.
About Pharmatek Laboratories, Inc.
Pharmatek Laboratories, Inc. is a premier pharmaceutical chemistry development organization supporting the pharmaceutical and biotechnology industries. Pharmatek focuses on bringing client compounds from discovery to the clinic with services that include compound selection, analytical development, preformulation testing, formulation development, GMP manufacturing and stability storage and testing.
Company Contact:
Elizabeth Hickman, Marketing Manager
Pharmatek Laboratories, Inc.
(858) 805-6383
ehickman@pharmatek.com
|
